Large gap with delayed quotes
|
Official
05/23/2026
-
02:04:00
|
Bid
05/22/2026 -
22:00:00
|
Bid Volume |
Ask
05/22/2026 -
22:00:00
|
Ask Volume |
|---|---|---|---|---|
|
76.42
-0.13
(
-0.17% )
|
76.41
|
1,700 |
76.46
|
1,300 |
Analysis date: 22.05.2026
Global Evaluation
Slightly positive
Slightly positive
The stock is classified in the slightly positive zone since 15.05.2026.
Interest
Weak
Weak
Two stars since 15.05.2026.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 15.05.2026 at a price of 74.63.
Evaluation
Neutral
Neutral
Based on its growth potential and our own criteria, we believe the share price is currently fairly priced.
MT Tech Trend
Negative
Negative
The dividend-adjusted forty day technical trend is negative since 24.04.2026.
4wk Rel Perf
-14.11%
-14.11%
The four-week dividend-adjusted underperformance versus SP500 is 14.11%.
Sensibility
Low
Low
The stock has been on the low-sensitivity level since 25.07.2025.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.69%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.29%.
Mkt Cap in $bn
3.70
3.70
With a market capitalization between $2 & $8bn, NATIONAL HEALTH INVESTORS is considered a mid-cap stock.
G/PE Ratio
0.90
0.90
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
21.64
21.64
The estimated PE is for the year 2027.
LT Growth
14.55%
14.55%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
3
3
Over the last seven weeks, an average of 3 analysts provided earnings per share estimates.
Dividend Yield
4.90%
4.90%
The earnings forecasts are not sufficient to cover the twelve month estimated dividend.
Beta
19
19
For 1% of index variation, the stock varies on average by 0.19%.
Correlation
0.13
0.13
Stock movements are totally independent of index variations.
Value at Risk
4.59
4.59
The value at risk is estimated at USD 4.59. The risk is therefore 6.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
25.07.2025
25.07.2025